How To Approach R/R Cll

How to approach R/R CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Therapeutic Approaches for R/R CLL

Primary analysis of TRANSCEND-CLL-004: liso-cel in R/R CLL

VJHemOnc – Video Journal of Hematology & HemOnc

The role of MRD in clinical decision-making in R/R CLL

VJHemOnc – Video Journal of Hematology & HemOnc

There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do?

Ven-based regimens for R/R CLL and considering an MRD-guided strategy

VJHemOnc – Video Journal of Hematology & HemOnc

Sequencing of therapies in patients with R/R CLL

VJHemOnc – Video Journal of Hematology & HemOnc

R/R CLL: combination therapy and tailored treatment

VJHemOnc – Video Journal of Hematology & HemOnc

Lisaftoclax ramp-up combined with acalabrutinib or rituximab in patients with CLL/SLL

VJHemOnc – Video Journal of Hematology & HemOnc

Venetoclax in RR CLL

Updated analysis of BELLWAVE-001: nemtabrutinib in R/R CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Additional Therapies for R/R CLL

BELLWAVE-001: nemtabrutinib in patients with R/R CLL/SLL

VJHemOnc – Video Journal of Hematology & HemOnc

EPCORE CLL-1: epcoritamab in patients with R/R CLL & Richter's transformation

VJHemOnc – Video Journal of Hematology & HemOnc

Sequence of administration of ibrutinib with obinutuzumab in R/R CLL patients

VJHemOnc – Video Journal of Hematology & HemOnc

Acalabrutinib vs ibrutinib in R/R CLL: assessing the burden of adverse events

VJHemOnc – Video Journal of Hematology & HemOnc

Epcore CLL-1: Phase I trial of epcoritamab in r/r CLL

VJHemOnc – Video Journal of Hematology & HemOnc

Venetoclax and ibrutinib for R/R CLL: analysis from the VIsion/HO141 trial

VJHemOnc – Video Journal of Hematology & HemOnc

Treating R/R CLL: the value of BTKis and venetoclax

VJHemOnc – Video Journal of Hematology & HemOnc

Safety and efficacy of NX-2127 in R/R CLL: a Phase I study

VJHemOnc – Video Journal of Hematology & HemOnc